NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Pfizer’s JAK1 inhibitor Cibinqo approved in US to treat atopic dermatitis

By NS Healthcare Staff Writer 17 Jan 2022

Cibinqo is an oral, once-daily, oral small molecule that selectively inhibits Janus kinase 1 (JAK1), to modulate multiple cytokines related to AD

1280px-Pfizer_World_Headquarters_Entrance

Gilead withdraws cancer drug Zydelig to treat NHL....

Zydelig will be continued as a treatment for CLL and FL in

Novavax’ protein-based Covid-19 vaccine approved in South Korea

Nuvaxovid, Novavax’ recombinant, adjuvanted Covid-19 vaccine, is the first protein-based Covid-19 shot

Pfizer unveils positive results for Prevnar 20, Comirnaty....

In the Phase 3 study, PREVNAR 20 vaccine triggered similar responses for

Vertex’s KAFTRIO + ivacaftor wins EU nod for....

The oral medicine has been approved for the treatment of cystic fibrosis

Pharmaceuticals

Pfizer partners with Beam to develop rare disease therapies
11 Jan 22

Acadia, Stoke to develop RNA-based treatments for neurodevelopmental diseases
11 Jan 22

Pfizer’s JAK1 inhibitor Cibinqo approved in US to treat atopic dermatitis

Gilead withdraws cancer drug Zydelig to treat NHL....

Novavax’ protein-based Covid-19 vaccine approved in South Korea

Pfizer unveils positive results for Prevnar 20, Comirnaty....

Vertex’s KAFTRIO + ivacaftor wins EU nod for....

Pharmaceuticals

Pfizer partners with Beam to develop rare disease therapies
11 Jan 22

Acadia, Stoke to develop RNA-based treatments for neurodevelopmental diseases
11 Jan 22

Sanofi partners with Exscientia to develop up to 15 new drug candidates
10 Jan 22

Patient Care

Thermo Fisher’s Oncomine Dx approved in US to identify NSCLC patients eligible for Rybrevant
10 Dec 21

Omicron variant spreads worldwide, with limited scientific information
29 Nov 21

Fujifilm rolls out ColoAssist PRO visualisation system for colonoscopies
25 Nov 21

Nutraceuticals

How sweet are sweeteners?
03 Nov 21

European Flavour Association: From farm to fork
28 Oct 21

Hope on the horizon for lactose intolerance
14 Oct 21

NS Healthcare is using cookies

Pfizer partners with Beam to develop rare disease therapies11 Jan 22

Acadia, Stoke to develop RNA-based treatments for neurodevelopmental diseases11 Jan 22

Sanofi partners with Exscientia to develop up to 15 new drug candidates10 Jan 22

Thermo Fisher’s Oncomine Dx approved in US to identify NSCLC patients eligible for Rybrevant 10 Dec 21

Omicron variant spreads worldwide, with limited scientific information 29 Nov 21

Fujifilm rolls out ColoAssist PRO visualisation system for colonoscopies 25 Nov 21

How sweet are sweeteners?03 Nov 21

European Flavour Association: From farm to fork28 Oct 21

Hope on the horizon for lactose intolerance14 Oct 21

OUR TITLES

Biogen obtains license for second SMA....05 Jan 22

Gilead selects AWS for development and....30 Nov 21

Click Therapeutics secures $52m in Series....25 Oct 21

The psychological toll of Covid-19 on....14 Sep 21

Novartis to acquire Gyroscope Therapeutics for....23 Dec 21

Sanofi to buy immuno-oncology firm Amunix....22 Dec 21

CSL agrees to buy Swiss firm....15 Dec 21

Pfizer to acquire Arena Pharmaceuticals in....14 Dec 21

AstraZeneca teams up with Ionis to....30 Dec 21

Novavax extends manufacturing agreement with South....24 Dec 21

Novartis teams up with BeiGene for....21 Dec 21

Lilly teams up with Regor to....13 Dec 21

Pfizer partners with Beam to develop rare disease therapies
11 Jan 22

Acadia, Stoke to develop RNA-based treatments for neurodevelopmental diseases
11 Jan 22

Sanofi partners with Exscientia to develop up to 15 new drug candidates
10 Jan 22

Thermo Fisher’s Oncomine Dx approved in US to identify NSCLC patients eligible for Rybrevant
10 Dec 21

Omicron variant spreads worldwide, with limited scientific information
29 Nov 21

Fujifilm rolls out ColoAssist PRO visualisation system for colonoscopies
25 Nov 21

How sweet are sweeteners?
03 Nov 21

European Flavour Association: From farm to fork
28 Oct 21

Hope on the horizon for lactose intolerance
14 Oct 21

Biogen obtains license for second SMA....
05 Jan 22

Gilead selects AWS for development and....
30 Nov 21

Click Therapeutics secures $52m in Series....
25 Oct 21

The psychological toll of Covid-19 on....
14 Sep 21

Novartis to acquire Gyroscope Therapeutics for....
23 Dec 21

Sanofi to buy immuno-oncology firm Amunix....
22 Dec 21

CSL agrees to buy Swiss firm....
15 Dec 21

Pfizer to acquire Arena Pharmaceuticals in....
14 Dec 21

AstraZeneca teams up with Ionis to....
30 Dec 21

Novavax extends manufacturing agreement with South....
24 Dec 21

Novartis teams up with BeiGene for....
21 Dec 21

Lilly teams up with Regor to....
13 Dec 21